Cargando…

Substitution Rtq267h of Hepatitis B Virus Increases the Weight of Replication and Lamivudine Resistance

BACKGROUND: Nucleus(t)ide analogs (NAs), containing Lamivudine (LMV), adefovir dipivoxil (ADV), endeavor (ETV), telbivudine (LdT), and tenofovir (TDF) are widely used for the treatment of chronic hepatitis B (CHB), but long term anti-Hepatitis B virus (HBV) therapy with NAs may give rise to the emer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Bo, Zhang, Bo, Zhang, Xiaodong, He, Tingting, Xu, Wenying, Fu, Lijun, Tu, Chunyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842524/ https://www.ncbi.nlm.nih.gov/pubmed/24348637 http://dx.doi.org/10.5812/hepatmon.12160

Ejemplares similares

Psychometric properties and factor structure of the Repetitive Thinking Questionnaire: Persian versions of the RTQ-31 and RTQ-10
por: Hasani, Mohsen, et al.
Publicado: (2021)

Clinical evaluation of the GSD NovaPrime® SARS-CoV-2 RTq-PCR assay
por: Tré-Hardy, Marie, et al.
Publicado: (2022)

Polymorphic Transformation and Magnetic Properties of Rapidly Solidified Fe(26.7)Co(26.7)Ni(26.7)Si(8.9)B(11.0) High-Entropy Alloys
por: Zhang, Zequn, et al.
Publicado: (2019)

Specific and reliable detection of Myosin 1C isoform A by RTqPCR in prostate cancer cells
por: Saidova, Aleena A., et al.
Publicado: (2018)

Euromech Colloquium 267
Publicado: (1990)

Lack of Effect of Lamivudine on Ebola Virus Replication
por: Hensley, Lisa E., et al.
Publicado: (2015)

Effect of S267F variant of NTCP on the patients with chronic hepatitis B
por: Lee, Hye Won, et al.
Publicado: (2017)

Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
por: Wang, Zhao, et al.
Publicado: (2011)

Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA
por: Paraskevis, Dimitrios, et al.
Publicado: (2010)

Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
por: Chen, En-Qiang, et al.
Publicado: (2009)

Inhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro
por: Jung, Jaesung, et al.
Publicado: (2015)

Coronary Anomalies in 11,267 Southwest Chinese Patients Determined by Angiography
por: Jiang, Xin, et al.
Publicado: (2021)

Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection
por: Uchida, Takuro, et al.
Publicado: (2021)

Lamivudine treatment for severe acute HBV hepatitis
por: Lisotti, Andrea, et al.
Publicado: (2008)

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
por: Kim, Jeong Han, et al.
Publicado: (2013)

Treatment of Hepatitis B Virus-Associated Membranous Nephropathy: Lamivudine Era versus Post-Lamivudine Era
por: Moon, Ju-Young, et al.
Publicado: (2012)

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
por: Park, Chan Ho, et al.
Publicado: (2016)

Optimizing mechanical properties of Fe(26.7)Co(26.7)Ni(26.7)Si(8.9)B(11) high entropy alloy by inducing hypoeutectic to quasi-duplex microstructural transition
por: Zhang, Ze-Qun, et al.
Publicado: (2019)

Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B
por: Chao, Daniel C, et al.
Publicado: (2013)

Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy
por: Wang, Changtai, et al.
Publicado: (2019)

Entecavir and lamivudine therapy for severe acute chronic hepatitis B
por: LIU, CHANGHONG, et al.
Publicado: (2013)

Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
por: Zhang, Yuan-Yuan, et al.
Publicado: (2009)

267 Dalbavancin for the treatment of Streptococcal Skin Infections
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

Lamivudine Therapy for Korean Children with Chronic Hepatitis B
por: Koh, Hong, et al.
Publicado: (2007)

Adefovir Dipivoxil Alone or in Combination with Ongoing Lamivudine in Patients with Decompensated Liver Disease and Lamivudine-resistant Hepatitis B Virus
por: Kim, Kang Mo, et al.
Publicado: (2005)

Detection of Plasmodium falciparum male and female gametocytes and determination of parasite sex ratio in human endemic populations by novel, cheap and robust RTqPCR assays
por: Santolamazza, Federica, et al.
Publicado: (2017)

Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
por: Sheng, Yun-Jian, et al.
Publicado: (2011)

Successful treatment of infantile hepatitis B with lamivudine: A case report
por: Zhang, Yu-Ting, et al.
Publicado: (2021)

Long-Term Outcomes and Dynamics of Mutants Associated with Lamivudine-Adefovir Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B
por: Kim, Jihyun, et al.
Publicado: (2015)

SAT-267 Pregnancy in Acromegaly: Report of Five Cases
por: Burcea, Iulia Florentina, et al.
Publicado: (2020)

267. Characteristics and Trends of Serratia Blood Stream Infections
por: Elabd, Hatem, et al.
Publicado: (2020)

Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B
por: Kanda, Tatsuo, et al.
Publicado: (2011)

High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B
por: Wani, Hamid Ullah, et al.
Publicado: (2014)

Intrinsic Replication Competences of HIV Strains After Zidovudine/Lamivudine/Nevirapine Treatment in the Philippines
por: Kageyama, Seiji, et al.
Publicado: (2019)

Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients
por: Lee, Heon Ju, et al.
Publicado: (2018)

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015)

Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China
por: Li, Si-Yue, et al.
Publicado: (2011)

Novel fluoronucleoside analog NCC inhibits lamivudine-resistant hepatitis B virus in a hepatocyte model
por: Zhang, Jingmin, et al.
Publicado: (2018)

Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B
por: Shakado, Satoshi, et al.
Publicado: (2008)

Lamivudine Therapy Exacerbates Bilirubinemia in Patients Underlying Severely Advanced Hepatitis
por: Choi, Young Hee, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u394j2skkh2cr4piqk8n1uhe0v